More severe side effects can include pancreatitis, vision changes, allergic reactions, fatigue or dizziness, gallstones, ...
In phase 2, VK2735 reduced patients' weight by about 15% after 13 weeks of treatment and maintained a clean safety profile.
With a market cap of $27.1 billion, DexCom, Inc. (DXCM) is a leading medical device company, specializing in continuous ...
After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...
"It's very, very clear that physician spending is not the problem in healthcare." -- Jen Brull, MD, president of the American ...
Nearly two-thirds (64%)  of Americans who have tried weight loss injections report the drugs as being “extremely effective” ...